These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 18773997

  • 21. Genetic polymorphisms of beta1 adrenergic receptor and their influence on the cardiovascular responses to metoprolol in a South Indian population.
    Mahesh Kumar KN, Ramu P, Rajan S, Shewade DG, Balachander J, Adithan C.
    J Cardiovasc Pharmacol; 2008 Nov; 52(5):459-66. PubMed ID: 19033826
    [Abstract] [Full Text] [Related]

  • 22. Polymorphisms of adrenoceptors are not associated with an increased risk of adverse event in heart failure: a MERIT-HF substudy.
    Savva J, Maqbool A, White HL, Galloway SL, Yuldasheva NY, Ball SG, West RM, De Boer RA, Van Veldhuisen DJ, Balmforth AJ, Merit-HF Study Group.
    J Card Fail; 2009 Jun; 15(5):435-41. PubMed ID: 19477404
    [Abstract] [Full Text] [Related]

  • 23. A novel polymorphism in the gene coding for the beta(1)-adrenergic receptor associated with survival in patients with heart failure.
    Börjesson M, Magnusson Y, Hjalmarson A, Andersson B.
    Eur Heart J; 2000 Nov; 21(22):1853-8. PubMed ID: 11052857
    [Abstract] [Full Text] [Related]

  • 24. Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol.
    Sehnert AJ, Daniels SE, Elashoff M, Wingrove JA, Burrow CR, Horne B, Muhlestein JB, Donahue M, Liggett SB, Anderson JL, Kraus WE.
    J Am Coll Cardiol; 2008 Aug 19; 52(8):644-51. PubMed ID: 18702968
    [Abstract] [Full Text] [Related]

  • 25. Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol.
    Johnson JA, Zineh I, Puckett BJ, McGorray SP, Yarandi HN, Pauly DF.
    Clin Pharmacol Ther; 2003 Jul 19; 74(1):44-52. PubMed ID: 12844134
    [Abstract] [Full Text] [Related]

  • 26. Beta1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to beta-blocker therapy.
    Terra SG, Hamilton KK, Pauly DF, Lee CR, Patterson JH, Adams KF, Schofield RS, Belgado BS, Hill JA, Aranda JM, Yarandi HN, Johnson JA.
    Pharmacogenet Genomics; 2005 Apr 19; 15(4):227-34. PubMed ID: 15864115
    [Abstract] [Full Text] [Related]

  • 27. Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: results from OPTIMIZE-HF.
    Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB, OPTIMIZE-HF Investigators and Coordinators.
    J Card Fail; 2007 Nov 19; 13(9):722-31. PubMed ID: 17996820
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Studies of associations between the Arg389Gly polymorphism of the beta1-adrenergic receptor gene (ADRB1) and hypertension and obesity in 7677 Danish white subjects.
    Gjesing AP, Andersen G, Albrechtsen A, Glümer C, Borch-Johnsen K, Jørgensen T, Hansen T, Pedersen O.
    Diabet Med; 2007 Apr 19; 24(4):392-7. PubMed ID: 17335470
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The Arg389Gly beta1-adrenergic receptor gene polymorphism and susceptibility to faint during head-up tilt test.
    Márquez MF, Hernández-Pacheco G, Hermosillo AG, Gómez JR, Cárdenas M, Vargas-Alarcón G.
    Europace; 2007 Aug 19; 9(8):585-8. PubMed ID: 17463065
    [Abstract] [Full Text] [Related]

  • 35. Impact of beta-2 Thr164Ile and combined beta-adrenergic receptor polymorphisms on prognosis in a cohort of heart failure outpatients.
    Biolo A, Salvaro R, Clausell N, Silvello D, Santos KG, Rohde LE.
    Braz J Med Biol Res; 2010 Jun 19; 43(6):565-71. PubMed ID: 20521014
    [Abstract] [Full Text] [Related]

  • 36. Frequency of genetic polymorphism for adrenergic receptor beta and cytochrome p450 2D6 enzyme, and effects on tolerability of beta-blocker therapy in heart failure with reduced ejection fraction patients: The Beta GenTURK study.
    Zoghi M, Kaya H, Çavuşoğlu Y, Aksakal E, Demir Ş, Yücel C, Mutlu H, Ergene O, Yılmaz MB, Beta GenTURK Study.
    Turk Kardiyol Dern Ars; 2016 Sep 19; 44(6):457-65. PubMed ID: 27665326
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Comparison of late mortality in hospitalized patients >70 years of age with systolic heart failure receiving beta blockers versus those not receiving beta blockers.
    Pascual-Figal DA, Redondo B, Caro C, Manzano S, Garrido IP, Ruipérez JA, Valdés M.
    Am J Cardiol; 2008 Dec 15; 102(12):1711-7. PubMed ID: 19064029
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.